Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury

Author:

Yamamoto Tatsuo1ORCID,Nakayama Isao2,Kawakatsu Yutaro1,Yamamoto Takumi1,Ishigami Naoyuki3,Watanuki Kei4,Okabe Takayoshi2,Yokoyama Hidetaro5

Affiliation:

1. Department of Nephrology; Fujieda Municipal General Hospital; Fujieda Japan

2. Department of Pharmacy; Fujieda Municipal General Hospital; Fujieda Japan

3. Department of Cardiovascular Surgery; Fujieda Municipal General Hospital; Fujieda Japan

4. Department of Oral Surgery; Fujieda Municipal General Hospital; Fujieda Japan

5. Medical Department; Seiryo Rehabilitation Hospital; Fujieda Japan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference30 articles.

1. Special issue: clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012;Japanese Society of Nephrology;Nihon Jinzo Gakkai Shi,2012

2. Kidney disease: improving global outcomes. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;KDIGO;Kidney Int Suppl,2013

3. NICE. National Institute for Health and Care Excellence Chronic kidney disease in adults: assessment and management 2014 https://www.nice.org.uk/guidance/cg182

4. Chronic kidney disease;Levey;Lancet,2012

5. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N Engl J Med,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3